Collaborative research for psoriatic disease

13 February 2025

By IFPA

IFPA Forum Americas 2025

Data on how psoriatic disease and related conditions impact different populations in the Americas remains scarce, with limited understanding of its prevalence and effects on health. Ongoing research is crucial to help inform evidence-based solutions. Strengthening medical guidelines and recommendations with real-world evidence ensures that treatment approaches are tailored to local needs and based on the latest scientific findings.

Related content

tool Advocacy, Toolkits

Design it right: A checklist for diverse, equitable, patient-first trials

tool Advocacy, Toolkits

Glossary: Common terms in clinical research

tool Advocacy, Toolkits

Before you join a study: A practical guide for participation in clinical trials

tool Advocacy, Toolkits

Breaking The Myths: Clinical trials and psoriatic disease

Combined Shape